The DOI matches its Crossref record; 418 of the 418 references it cites were found in a registry or an index.
Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches
Open accessAbstract
Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung architecture disruption and respiratory failure. The development of pulmonary fibrosis is mostly the result of previous acute lung inflammation, caused by a wide variety of etiological factors, not resolved over time and causing the deposition of fibrotic tissue in the lungs. Despite a long history of study and good coverage of the problem in the scientific literature, the effective therapeutic approaches for pulmonary fibrosis treatment are currently lacking. Thus, the study of the molecular mechanisms underlying the transition from acute lung inflammation to pulmonary fibrosis, and the search for new molecular markers and promising therapeutic targets to prevent pulmonary fibrosis development, remain highly relevant tasks. This review focuses on the etiology, pathogenesis, morphological characteristics and outcomes of acute lung inflammation as a precursor of pulmonary fibrosis; the pathomorphological changes in the lungs during fibrosis development; the known molecular mechanisms and key players of the signaling pathways mediating acute lung inflammation and pulmonary fibrosis, as well as the characteristics of the most common in vivo models of these processes. Moreover, the prognostic markers of acute lung injury severity and pulmonary fibrosis development as well as approved and potential therapeutic approaches suppressing the transition from acute lung inflammation to fibrosis are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Bellani, G., Laffey, J. G., Pham, T., Fan, E., Brochard, L., Esteban, A., Gattinoni, L., van Haren, F., Larsson, A., McAuley, D. F., et al. (2016) · JAMA · doi:10.1001/jama.2016.0291 · Cited by 5,766
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Mutations affecting segment number and polarity in Drosophila
Nüsslein-Volhard, C., & Wieschaus, E. (1980) · Nature · doi:10.1038/287795a0 · Cited by 4,370
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,290
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Hedgehog signaling in animal development: paradigms and principles
Ingham, P. W., & McMahon, A. P. (2001) · Genes & Development · doi:10.1101/gad.938601 · Cited by 2,985
Ventilator-induced Lung Injury: Lessons from Experimental Studies
DREYFUSS, D., & SAUMON, G. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9604014 · Cited by 2,297
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,783
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Animal models of acute lung injury
Matute-Bello, G., Frevert, C. W., & Martin, T. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00010.2008 · Cited by 1,728
Formation and function of the myofibroblast during tissue repair
Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658
Signal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Calfee, C. S., Delucchi, K., Parsons, P. E., Thompson, B. T., Ware, L. B., & Matthay, M. A. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70097-9 · Cited by 1,544
Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2938 · Cited by 1,522
Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment
Fan, E., Brodie, D., & Slutsky, A. S. (2018) · JAMA · doi:10.1001/jama.2017.21907 · Cited by 1,470
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Alveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Transforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,278
Integrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
Leung, C. C., Yu, I. T. S., & Chen, W. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60235-9 · Cited by 1,193
Biernacka, A., Dobaczewski, M., & Frangogiannis, N. G. (2011) · Growth Factors · doi:10.3109/08977194.2011.595714 · Cited by 1,161
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Richeldi, L., Costabel, U., Selman, M., Kim, D. S., Hansell, D. M., Nicholson, A. G., Brown, K. K., Flaherty, K. R., Noble, P. W., Raghu, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103690 · Cited by 1,157
Acute respiratory distress syndrome
Meyer, N. J., Gattinoni, L., & Calfee, C. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00439-6 · Cited by 1,144
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Hilberg, F., Roth, G. J., Krssak, M., Kautschitsch, S., Sommergruber, W., Tontsch-Grunt, U., Garin-Chesa, P., Bader, G., Zoephel, A., Quant, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6307 · Cited by 1,056
Rock, J. R., Barkauskas, C. E., Cronce, M. J., Xue, Y., Harris, J. R., Liang, J., Noble, P. W., & Hogan, B. L. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117988108 · Cited by 1,030
Bray, S. J. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.94 · Cited by 1,012
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Preparing for the First Breath: Genetic and Cellular Mechanisms in Lung Development
Morrisey, E. E., & Hogan, B. L. M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.010 · Cited by 964
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-571oc · Cited by 954
Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., & Borok, Z. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62351-6 · Cited by 951
Fubini, B., & Hubbard, A. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00149-7 · Cited by 935
Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., & Kitani, A. (2006) · Nature Medicine · doi:10.1038/nm1332 · Cited by 889
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2014 · Cited by 874
TGF-β Activation and Function in Immunity
Travis, M. A., & Sheppard, D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120257 · Cited by 856
Wang, Y., Xu, C.-F., Liu, Y.-J., Mao, Y.-F., Lv, Z., Li, S.-Y., Zhu, X.-Y., & Jiang, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477112 · Cited by 825
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Murine models of pulmonary fibrosis
Moore, B. B., & Hogaboam, C. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2007 · Cited by 796
Patched acts catalytically to suppress the activity of Smoothened
Taipale, J., Cooper, M. K., Maiti, T., & Beachy, P. A. (2002) · Nature · doi:10.1038/nature00989 · Cited by 794
Regulation of PDGF and its receptors in fibrotic diseases
Bonner, J. C. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.006 · Cited by 768
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
Metalloproteinases and their inhibitors: Regulators of wound healing
Gill, S. E., & Parks, W. C. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.024 · Cited by 742
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730
Parsons, P. E., Eisner, M. D., Thompson, B. T., Matthay, M. A., Ancukiewicz, M., Bernard, G. R., & Wheeler, A. P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000149854.61192.dc · Cited by 723
Bone marrow–derived progenitor cells in pulmonary fibrosis
Hashimoto, N., Jin, H., Liu, T., Chensue, S. W., & Phan, S. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18847 · Cited by 720
Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
The Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers
Fernandez, I. E., & Eickelberg, O. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201203-023aw · Cited by 679
Sasaki, H., Hui, C.-C., Nakafuku, M., & Kondoh, H. (1997) · Development · doi:10.1242/dev.124.7.1313 · Cited by 674
Bleomycins: towards better therapeutics
Chen, J., & Stubbe, J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1547 · Cited by 664
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Wollin, L., Maillet, I., Quesniaux, V., Holweg, A., & Ryffel, B. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208223 · Cited by 633
Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality
Ramirez, J. A., Wiemken, T. L., Peyrani, P., Arnold, F. W., Kelley, R., Mattingly, W. A., Nakamatsu, R., Pena, S., Guinn, B. E., Furmanek, S. P., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix647 · Cited by 624
Superoxide Dismutases in the Lung and Human Lung Diseases
Kinnula, V. L., & Crapo, J. D. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200212-1479so · Cited by 620
Extracellular matrix as a driver of progressive fibrosis
Herrera, J., Henke, C. A., & Bitterman, P. B. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93557 · Cited by 615
Lung development: orchestrating the generation and regeneration of a complex organ
Herriges, M., & Morrisey, E. E. (2014) · Development · doi:10.1242/dev.098186 · Cited by 613
Global incidence and prevalence of idiopathic pulmonary fibrosis
Maher, T. M., Bendstrup, E., Dron, L., Langley, J., Smith, G., Khalid, J. M., Patel, H., & Kreuter, M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01791-z · Cited by 612
Interleukin‐18: Biological properties and role in disease pathogenesis
Kaplanski, G. (2018) · Immunological Reviews · doi:10.1111/imr.12616 · Cited by 606
The radiotherapeutic injury – a complex ‘wound’
Denham, J. W., & Hauer-Jensen, M. (2002) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(02)00060-9 · Cited by 596
Pulmonary fibrosis: patterns and perpetrators
Noble, P. W., Barkauskas, C. E., & Jiang, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60323 · Cited by 595
MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Rosas, I. O., Richards, T. J., Konishi, K., Zhang, Y., Gibson, K., Lokshin, A. E., Lindell, K. O., Cisneros, J., MacDonald, S. D., Pardo, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050093 · Cited by 588
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583
Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung Injury
Dolinay, T., Kim, Y. S., Howrylak, J., Hunninghake, G. M., An, C. H., Fredenburgh, L., Massaro, A. F., Rogers, A., Gazourian, L., Nakahira, K., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0003oc · Cited by 563
Jiao, Y., Zhang, T., Zhang, C., Ji, H., Tong, X., Xia, R., Wang, W., Ma, Z., & Shi, X. (2021) · Critical Care · doi:10.1186/s13054-021-03775-3 · Cited by 558
Cell mechanics and mechanotransduction: pathways, probes, and physiology
Huang, H., Kamm, R. D., & Lee, R. T. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00559.2003 · Cited by 548
Fibrotic extracellular matrix activates a profibrotic positive feedback loop
Parker, M. W., Rossi, D., Peterson, M., Smith, K., Sikström, K., White, E. S., Connett, J. E., Henke, C. A., Larsson, O., & Bitterman, P. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71386 · Cited by 548
Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome
PARK, W. Y., GOODMAN, R. B., STEINBERG, K. P., RUZINSKI, J. T., RADELLA, F., PARK, D. R., PUGIN, J., SKERRETT, S. J., HUDSON, L. D., & MARTIN, T. R. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2104013 · Cited by 547
de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 535
King, T. E., Albera, C., Bradford, W. Z., Costabel, U., Hormel, P., Lancaster, L., Noble, P. W., Sahn, S. A., Szwarcberg, J., Thomeer, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60551-1 · Cited by 531
Multistep Navigation and the Combinatorial Control of Leukocyte Chemotaxis
Foxman, E. F., Campbell, J. J., & Butcher, E. C. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1349 · Cited by 528
Inflammation and immunity in IPF pathogenesis and treatment
Heukels, P., Moor, C. C., von der Thüsen, J. H., Wijsenbeek, M. S., & Kool, M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.015 · Cited by 517
Developmental pathways in the pathogenesis of lung fibrosis
Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., De Langhe, S. P., & Thannickal, V. J. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.004 · Cited by 514
Isothiocyanate compounds as fluorescent labeling agents for immune serum.
Riggs, J. L., Seiwald, R. J., Burckhalter, J. H., DOWNS, C. M., & Metcalf, T. G. (2000) · PubMed · Cited by 512
Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
Königshoff, M., Balsara, N., Pfaff, E.-M., Kramer, M., Chrobak, I., Seeger, W., & Eickelberg, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002142 · Cited by 507
Statistical Evaluation of a Biomarker
Ray, P., Manach, Y. L., Riou, B., Houle, T. T., & Warner, D. S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181d47604 · Cited by 503
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497
Gene Overexpression: Uses, Mechanisms, and Interpretation
Prelich, G. (2012) · Genetics · doi:10.1534/genetics.111.136911 · Cited by 490
New Serum Indicator of Interstitial Pneumonitis Activity
Nobuoki, K., Seishi, K., Yukikazu, A., Hirofumi, F., Michio, Y., & Mitoshi, A. (1989) · Chest · doi:10.1378/chest.96.1.68 · Cited by 486
Pulmonary macrophages: key players in the innate defence of the airways
Byrne, A. J., Mathie, S. A., Gregory, L. G., & Lloyd, C. M. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207020 · Cited by 484
The Bone Marrow Functionally Contributes to Liver Fibrosis
Russo, F. P., Alison, M. R., Bigger, B. W., Amofah, E., Florou, A., Amin, F., Bou–Gharios, G., Jeffery, R., Iredale, J. P., & Forbes, S. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.036 · Cited by 483
Burgstaller, G., Oehrle, B., Gerckens, M., White, E. S., Schiller, H. B., & Eickelberg, O. (2017) · European Respiratory Journal · doi:10.1183/13993003.01805-2016 · Cited by 482
Invited Review: Mechanisms of ventilator-induced lung injury: a perspective
Dos Santos, C. C., & Slutsky, A. S. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.4.1645 · Cited by 458
Two pathways for lysophosphatidic acid production
AOKI, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.06.005 · Cited by 448
Humke, E. W., Dorn, K. V., Milenkovic, L., Scott, M. P., & Rohatgi, R. (2010) · Genes & Development · doi:10.1101/gad.1902910 · Cited by 444
Oku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I., Ueyama, A., Matsushima, S., Torii, M., & Arimura, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.046 · Cited by 436
Pilling, D., Fan, T., Huang, D., Kaul, B., & Gomer, R. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007475 · Cited by 433
Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms.
Folkesson, H. G., Matthay, M. A., Hébert, C. A., & Broaddus, V. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118009 · Cited by 422
The role of periostin in tissue remodeling across health and disease
Conway, S. J., Izuhara, K., Kudo, Y., Litvin, J., Markwald, R., Ouyang, G., Arron, J. R., Holweg, C. T. J., & Kudo, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1494-y · Cited by 421
Martinet, Y., Rom, W. N., Grotendorst, G. R., Martin, G. R., & Crystal, R. G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170404 · Cited by 414
Animal Models of Fibrotic Lung Disease
B. Moore, B., Lawson, W. E., Oury, T. D., Sisson, T. H., Raghavendran, K., & Hogaboam, C. M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0094tr · Cited by 412
Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms
He, Y.-Q., Zhou, C.-C., Yu, L.-Y., Wang, L., Deng, J.-L., Tao, Y.-L., Zhang, F., & Chen, W.-S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105224 · Cited by 412
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice
Zhao, J., Shi, W., Wang, Y.-L., Chen, H., Bringas, P., Datto, M. B., Frederick, J. P., Wang, X.-F., & Warburton, D. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00151.2001 · Cited by 411
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K., & Iwamoto, I. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6094 · Cited by 405
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
Abdollahi, A., Li, M., Ping, G., Plathow, C., Domhan, S., Kiessling, F., Lee, L. B., McMahon, G., Gröne, H.-J., Lipson, K. E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041393 · Cited by 388
The role of the extracellular matrix components in cutaneous wound healing
Olczyk, P., Mencner, Ł., & Komosinska-Vassev, K. (2014) · BioMed Research International · doi:10.1155/2014/747584 · Cited by 387 · cited 10×
“It is a widely documented fact that the deposition of different ECM components, including collagen types I, III and V, fibronectin, tenascin and proteoglycans (lumican and biglycan) is increased during IPF, COPD and ARDS [90,91], and in turn, the main effector cells responsible for the increased production of ECM prot…”
BackgroundInfluentialDistinct Molecular Phenotypes of Direct vs Indirect ARDS in Single-Center and Multicenter Studies
Calfee, C. S., Janz, D. R., Bernard, G. R., May, A. K., Kangelaris, K. N., Matthay, M. A., & Ware, L. B. (2015) · Chest · doi:10.1378/chest.14-2454 · Cited by 386
MORI, L., BELLINI, A., STACEY, M., SCHMIDT, M., & MATTOLI, S. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.11.011 · Cited by 382
Morgenstern, D. E., Gifford, M. A. C., Li, L. L., Doerschuk, C. M., & Dinauer, M. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.2.207 · Cited by 370 · cited 1×
“The etiological factors of inflammation can become persistent due to a wide variety of reasons: defects of phagocytic NADPH oxidase and ROS production, necessary for the elimination of bacterial pathogens [73]; prolonged or constant influence of irritants or external particles, which cannot be eliminated through enzym…”
BackgroundTreatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial
Raghu, G., Brown, K. K., Costabel, U., Cottin, V., du Bois, R. M., Lasky, J. A., Thomeer, M., Utz, J. P., Khandker, R. K., McDermott, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1446oc · Cited by 370
Wnt Signaling Induces Matrix Metalloproteinase Expression and Regulates T Cell Transmigration
Wu, B., Crampton, S. P., & Hughes, C. C. W. (2007) · Immunity · doi:10.1016/j.immuni.2006.12.007 · Cited by 369
Oliver, T. G., Grasfeder, L. L., Carroll, A. L., Kaiser, C., Gillingham, C. L., Lin, S. M., Wickramasinghe, R., Scott, M. P., & Wechsler-Reya, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832317100 · Cited by 367
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
O’Dwyer, D. N., Ashley, S. L., Gurczynski, S. J., Xia, M., Wilke, C., Falkowski, N. R., Norman, K. C., Arnold, K. B., Huffnagle, G. B., Salisbury, M. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1650oc · Cited by 366
Celada, L. J., Kropski, J. A., Herazo-Maya, J. D., Luo, W., Creecy, A., Abad, A. T., Chioma, O. S., Lee, G., Hassell, N. E., Shaginurova, G. I., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar8356 · Cited by 363
TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
Murray, L. A., Chen, Q., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Peng, X., Gulati, M., Homer, R. J., Russell, T., van Rooijen, N., et al. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.10.013 · Cited by 362
The Bleomycin Model of Pulmonary Fibrosis
Liu, T., De Los Santos, F. G., & Phan, S. H. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7113-8_2 · Cited by 357
Santa Cruz, A., Mendes-Frias, A., Oliveira, A. I., Dias, L., Matos, A. R., Carvalho, A., Capela, C., Pedrosa, J., Castro, A. G., & Silvestre, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613422 · Cited by 355
Pathogenesis of fibrosis: role of TGF-β and CTGF
Ihn, H. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200211000-00009 · Cited by 354
Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice
Haudek, S. B., Xia, Y., Huebener, P., Lee, J. M., Carlson, S., Crawford, J. R., Pilling, D., Gomer, R. H., Trial, J., Frangogiannis, N. G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608799103 · Cited by 338
Idiopathic Pulmonary Fibrosis: Aberrant Recapitulation of Developmental Programs?
Selman, M., Pardo, A., & Kaminski, N. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050062 · Cited by 336
Heterogeneous Increase in CD34-positive Alveolar Capillaries in Idiopathic Pulmonary Fibrosis
Ebina, M., Shimizukawa, M., Shibata, N., Kimura, Y., Suzuki, T., Endo, M., Sasano, H., Kondo, T., & Nukiwa, T. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1111oc · Cited by 320
Scotton, C. J., Krupiczojc, M. A., Königshoff, M., Mercer, P. F., Lee, Y. C. G., Kaminski, N., Morser, J., Post, J. M., Maher, T. M., Nicholson, A. G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33288 · Cited by 319
Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis
Degryse, A. L., Tanjore, H., Xu, X. C., Polosukhin, V. V., Jones, B. R., McMahon, F. B., Gleaves, L. A., Blackwell, T. S., & Lawson, W. E. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00026.2010 · Cited by 311
Prevalence and prognosis of unclassifiable interstitial lung disease
Ryerson, C. J., Urbania, T. H., Richeldi, L., Mooney, J. J., Lee, J. S., Jones, K. D., Elicker, B. M., Koth, L. L., King, T. E., Wolters, P. J., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00131912 · Cited by 310
Inhibition of Fibrocyte Differentiation by Serum Amyloid P
Pilling, D., Buckley, C. D., Salmon, M., & Gomer, R. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5537 · Cited by 308
Bartis, D., Mise, N., Mahida, R. Y., Eickelberg, O., & Thickett, D. R. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204608 · Cited by 307
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris
Duchemann, B., Annesi-Maesano, I., Jacobe de Naurois, C., Sanyal, S., Brillet, P.-Y., Brauner, M., Kambouchner, M., Huynh, S., Naccache, J. M., Borie, R., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02419-2016 · Cited by 304
Kuwana, M., Okazaki, Y., Kodama, H., Izumi, K., Yasuoka, H., Ogawa, Y., Kawakami, Y., & Ikeda, Y. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403170 · Cited by 303
Transforming Growth Factor β: A Central Modulator of Pulmonary and Airway Inflammation and Fibrosis
Sheppard, D. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-008aw · Cited by 298
Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress
Ahmadinejad, F., Geir Møller, S., Hashemzadeh-Chaleshtori, M., Bidkhori, G., & Jami, M.-S. (2017) · Antioxidants · doi:10.3390/antiox6030051 · Cited by 297
Tissue repair: The hidden drama
Krafts, K. P. (2010) · Organogenesis · doi:10.4161/org.6.4.12555 · Cited by 293
The myofibroblast in wound healing and fibrosis: answered and unanswered questions
Bochaton-Piallat, M.-L., Gabbiani, G., & Hinz, B. (2016) · F1000Research · doi:10.12688/f1000research.8190.1 · Cited by 293
Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis
Kheirollahi, V., Wasnick, R. M., Biasin, V., Vazquez-Armendariz, A. I., Chu, X., Moiseenko, A., Weiss, A., Wilhelm, J., Zhang, J.-S., Kwapiszewska, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10839-0 · Cited by 293
A key role for nox4 in epithelial cell death during development of lung fibrosis
Carnesecchi, S., Deffert, C., Donati, Y., Basset, O., Hinz, B., Preynat-Seauve, O., Guichard, C., Arbiser, J. L., Banfi, B., Pache, J.-C., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3829 · Cited by 290
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Ramasamy, S., & Subbian, S. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00299-20 · Cited by 289
Matrix abnormalities in pulmonary fibrosis
Upagupta, C., Shimbori, C., Alsilmi, R., & Kolb, M. (2018) · European Respiratory Review · doi:10.1183/16000617.0033-2018 · Cited by 285
A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration
Zhang, Y., Goss, A. M., Cohen, E. D., Kadzik, R., Lepore, J. J., Muthukumaraswamy, K., Yang, J., DeMayo, F. J., Whitsett, J. A., Parmacek, M. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.157 · Cited by 284
Vetrone, S. A., Montecino-Rodriguez, E., Kudryashova, E., Kramerova, I., Hoffman, E. P., Liu, S. D., Miceli, M. C., & Spencer, M. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37662 · Cited by 279
ARDS: clinical lessons from the oleic acid model of acute lung injury.
Schuster, D. P. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.1.8111590 · Cited by 276
Hinz, B. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.09.004 · Cited by 274
Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants
Laskin, D. L., Malaviya, R., & Laskin, J. D. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfy309 · Cited by 267
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine
Spadaro, S., Park, M., Turrini, C., Tunstall, T., Thwaites, R., Mauri, T., Ragazzi, R., Ruggeri, P., Hansel, T. T., Caramori, G., et al. (2019) · Journal of Inflammation · doi:10.1186/s12950-018-0202-y · Cited by 266
Hartlapp, I., Abe, R., Saeed, R. W., Peng, T., Voelter, W., Bucala, R., & Metz, C. N. (2001) · The FASEB Journal · doi:10.1096/fj.01-0049com · Cited by 265
Zhou, B., Liu, Y., Kahn, M., Ann, D. K., Han, A., Wang, H., Nguyen, C., Flodby, P., Zhong, Q., Krishnaveni, M. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276311 · Cited by 261
Biomarkers in Acute Lung Injury: Insights into the Pathogenesis of Acute Lung Injury
Cross, L. J. M., & Matthay, M. A. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.12.005 · Cited by 256
Sun, L., Louie, M. C., Vannella, K. M., Wilke, C. A., LeVine, A. M., Moore, B. B., & Shanley, T. P. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00122.2010 · Cited by 251
Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Patel, N. M., Lederer, D. J., Borczuk, A. C., & Kawut, S. M. (2007) · Chest · doi:10.1378/chest.06-3087 · Cited by 248
Wnt signalling in lung development and diseases
Pongracz, J. E., & Stockley, R. A. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-15 · Cited by 242
Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease
Aschner, Y., & Downey, G. P. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0391tr · Cited by 237
Kong, L., Deng, J., Zhou, X., Cai, B., Zhang, B., Chen, X., Chen, Z., & Wang, W. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04227-0 · Cited by 237
Volckaert, T., Dill, E., Campbell, A., Tiozzo, C., Majka, S., Bellusci, S., & De Langhe, S. P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58097 · Cited by 236
Fibrocytes: a unique cell population implicated in wound healing
Metz, C. N. (2003) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-003-2328-0 · Cited by 235
Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections
Memar, M. Y., Yekani, M., Alizadeh, N., & Baghi, H. B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.142 · Cited by 234
Myofibroblast development is characterized by specific cell-cell adherens junctions
Hinz, B., Pittet, P., Smith-Clerc, J., Chaponnier, C., & Meister, J.-J. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-05-0386 · Cited by 231
Maher, T. M., van der Aar, E. M., Van de Steen, O., Allamassey, L., Desrivot, J., Dupont, S., Fagard, L., Ford, P., Fieuw, A., & Wuyts, W. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30181-4 · Cited by 231
Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P
Pilling, D., Roife, D., Wang, M., Ronkainen, S. D., Crawford, J. R., Travis, E. L., & Gomer, R. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4035 · Cited by 230
Raghu, G., van den Blink, B., Hamblin, M. J., Brown, A. W., Golden, J. A., Ho, L. A., Wijsenbeek, M. S., Vasakova, M., Pesci, A., Antin-Ozerkis, D. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.6129 · Cited by 227
Oczypok, E. A., Perkins, T. N., & Oury, T. D. (2017) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2017.03.012 · Cited by 226
Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure
Nevers, T., Salvador, A. M., Velazquez, F., Ngwenyama, N., Carrillo-Salinas, F. J., Aronovitz, M., Blanton, R. M., & Alcaide, P. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161791 · Cited by 226
Juban, G., Saclier, M., Yacoub-Youssef, H., Kernou, A., Arnold, L., Boisson, C., Ben Larbi, S., Magnan, M., Cuvellier, S., Théret, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.077 · Cited by 221
Howell, D. C. J., Johns, R. H., Lasky, J. A., Shan, B., Scotton, C. J., Laurent, G. J., & Chambers, R. C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62354-1 · Cited by 218
WNT5A Is a Regulator of Fibroblast Proliferation and Resistance to Apoptosis
Vuga, L. J., Ben-Yehudah, A., Kovkarova-Naumovski, E., Oriss, T., Gibson, K. F., Feghali-Bostwick, C., & Kaminski, N. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0201oc · Cited by 215
Ye, R., & Liu, Z. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104350 · Cited by 205
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis
Pardo, A., & Selman, M. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-341aw · Cited by 204
Meyer, A., Wang, W., Qu, J., Croft, L., Degen, J. L., Coller, B. S., & Ahamed, J. (2012) · Blood · doi:10.1182/blood-2011-09-377648 · Cited by 203
Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis
Ohshimo, S., Ishikawa, N., Horimasu, Y., Hattori, N., Hirohashi, N., Tanigawa, K., Kohno, N., Bonella, F., Guzman, J., & Costabel, U. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.04.009 · Cited by 201
Ito, J. T., Lourenço, J. D., Righetti, R. F., Tibério, I. F. L. C., Prado, C. M., & Lopes, F. D. T. Q. S. (2019) · Cells · doi:10.3390/cells8040342 · Cited by 196
Murray, L. A., Rosada, R., Moreira, A. P., Joshi, A., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Mathai, S., Gulati, M., Herzog, E. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009683 · Cited by 192
Th17-Polarized Immune Response in a Murine Model of Hypersensitivity Pneumonitis and Lung Fibrosis
Simonian, P. L., Roark, C. L., Wehrmann, F., Lanham, A. K., Diaz del Valle, F., Born, W. K., O’Brien, R. L., & Fontenot, A. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.657 · Cited by 190
Activation of Alveolar Macrophages via the Alternative Pathway in Herpesvirus-Induced Lung Fibrosis
Mora, A. L., Torres-González, E., Rojas, M., Corredor, C., Ritzenthaler, J., Xu, J., Roman, J., Brigham, K., & Stecenko, A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0121oc · Cited by 190
Increasingly complex: New players enter the Wnt signaling network
Pandur, P., Maurus, D., & Kühl, M. (2002) · BioEssays · doi:10.1002/bies.10164 · Cited by 188
Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice
Zhang, B., Liu, Z.-Y., Li, Y.-Y., Luo, Y., Liu, M.-L., Dong, H.-Y., Wang, Y.-X., Liu, Y., Zhao, P.-T., Jin, F.-G., et al. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.09.020 · Cited by 186
Hetzel, M., Bachem, M., Anders, D., Trischler, G., & Faehling, M. (2005) · Lung · doi:10.1007/s00408-004-2534-z · Cited by 186
Raghu, G., & Selman, M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201411-2044ed · Cited by 185
Molecular Dynamics of Lipopolysaccharide-Induced Lung Injury in Rodents
Domscheit, H., Hegeman, M. A., Carvalho, N., & Spieth, P. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00036 · Cited by 184
Maggi, E., Cosmi, L., Liotta, F., Romagnani, P., Romagnani, S., & Annunziato, F. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.04.010 · Cited by 183
WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis
Aumiller, V., Balsara, N., Wilhelm, J., Günther, A., & Königshoff, M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0524oc · Cited by 181
Mohanty, S. K., Satapathy, A., Naidu, M. M., Mukhopadhyay, S., Sharma, S., Barton, L. M., Stroberg, E., Duval, E. J., Pradhan, D., Tzankov, A., et al. (2020) · Diagnostic Pathology · doi:10.1186/s13000-020-01017-8 · Cited by 181
Marchal-Sommé, J., Uzunhan, Y., Marchand-Adam, S., Valeyre, D., Soumelis, V., Crestani, B., & Soler, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5735 · Cited by 179
High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations
Papiris, S. A., Tomos, I. P., Karakatsani, A., Spathis, A., Korbila, I., Analitis, A., Kolilekas, L., Kagouridis, K., Loukides, S., Karakitsos, P., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2017.08.019 · Cited by 179
HANT, F. N., LUDWICKA-BRADLEY, A., WANG, H.-J., LI, N., ELASHOFF, R., TASHKIN, D. P., & SILVER, R. M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080633 · Cited by 177
Keratinocyte growth factor reduces lung damage due to acid instillation in rats.
Yano, T., Deterding, R. R., Simonet, W. S., Shannon, J. M., & Mason, R. J. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.15.4.8879176 · Cited by 177
Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis
Postlethwaite, A. E., Shigemitsu, H., & Kanangat, S. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000139310.77347.9c · Cited by 174
A Role for Vascular Endothelial Growth Factor in Acute and Resolving Lung Injury
Thickett, D. R., Armstrong, L., & Millar, A. B. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105057 · Cited by 174
Smooth Muscle α-Actin Is a Direct Target of Notch/CSL
Noseda, M., Fu, Y., Niessen, K., Wong, F., Chang, L., McLean, G., & Karsan, A. (2006) · Circulation Research · doi:10.1161/01.res.0000229683.81357.26 · Cited by 174
Marmai, C., Sutherland, R. E., Kim, K. K., Dolganov, G. M., Fang, X., Kim, S. S., Jiang, S., Golden, J. A., Hoopes, C. W., Matthay, M. A., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00212.2010 · Cited by 172
A cohort study of interstitial lung diseases in central Denmark
Hyldgaard, C., Hilberg, O., Muller, A., & Bendstrup, E. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2013.09.002 · Cited by 171
Cutroneo, K. R., White, S. L., Phan, S. H., & Ehrlich, H. P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20972 · Cited by 170
Mikacenic, C. R., Moore, R., Dmyterko, V., West, T. E., Altemeier, W. A., Liles, W. C., & Lood, C. (2018) · Critical Care · doi:10.1186/s13054-018-2290-8 · Cited by 169
Biomarkers in acute lung injury
Bhargava, M., & Wendt, C. H. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.007 · Cited by 168
Reversible differentiation of myofibroblasts by MyoD
Hecker, L., JAGIRDAR, R. M., Jin, T., & Thannickal, V. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.03.016 · Cited by 168
Clara Cells and Clara Cell 10 kD Protein (CC10)
Singh, G., & Katyal, S. L. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.2.f138 · Cited by 167
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
Brunetta, E., Folci, M., Bottazzi, B., Santis, M. D., Gritti, G., Protti, A., Mapelli, S. N., Bonovas, S., Piovani, D., Leone, R., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00832-x · Cited by 167
Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight
Lamort, A.-S., Giopanou, I., Psallidas, I., & Stathopoulos, G. T. (2019) · Cells · doi:10.3390/cells8080815 · Cited by 166
Nova, Z., Skovierova, H., & Calkovska, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040831 · Cited by 164
Cited by
Yan, J., Wang, S.-Y., Su, Q., Zou, M.-W., Zhou, Z.-Y., Shou, J., & Huo, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-59093-7 · Cited by 62
Zeyada, M. S., Eraky, S. M., & El-Shishtawy, M. M. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122272 · Cited by 31
Metadata
- Authors
- Savin, I. A., Zenkova, M. A., & Sen’kova, A. V.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-11-29
- Volume
- 23
- Issue
- 23
- Pages
- 14959
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4311040528
- Cited by
- 279
- References
- 418
- FWCI
- 29.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.